Self-Managed Medication Abortion: Implications for Clinical Practice

Abstract

Medication abortion represents more than 50 percent of abortions in the United States (US). Since its approval in the US in 2000, the Food and Drug Administration (FDA) has progressively relaxed the prescribing requirements such that currently, no office visit, in-person dispensing, or ultrasound is required. Obtaining medication for abortion online without medical supervision or evaluation is also possible. This article reviews the complications of medication abortion by examining major studies and delineates the risks specific to self-managed abortion to inform clinicians in caring for women.

Summary

Medication abortion has become the most common abortion method in the United States. This document provides a detailed history of the relaxation requirements on medication abortion and reviews the major studies on medication abortion complications including a discussion of their limitations. Finally, the paper delineates the ease of access to medication abortion without a health care provider and the risks associated with self-managed abortion. This paper is intended to provide information for clinicians who likely will be encountering increasing number of patients with such complications.

Keywords

Abortion Abortion complications Gynecology Obstetrical care Roe v. Wade Women’s reproductive health Women’s reproductive issues Medication Abortion Chemical Abortion Mifepristone Misoprostol

Get full access to this article

View all access options for this article.

References

Abortion Care Network. 2020. “Communities Need Clinics: The Essential Role of Independent Abortion Clinics in the United States.” https://abortioncarenetwork.org/wp-content/uploads/2020/12/CommunitiesNeedClinics-2020.pdf.

ACOG. 2017a. “Committee Opinion No 700: Methods for Estimating the Due Date.” Obstetrics & Gynecology 129 (5): e150-e154. https://doi.org/10.1097/AOG.0000000000002046. https://www.ncbi.nlm.nih.gov/pubmed/28426621.

ACOG. 2017b. “Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.” Obstetrics & Gynecology 130 (2): e57-e70. https://doi.org/10.1097/AOG.0000000000002232. https://www.ncbi.nlm.nih.gov/pubmed/28742673.

ACOG. 2018. “ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy.” Obstetrics & Gynecology 131 (3): e91-e103. https://doi.org/10.1097/AOG.0000000000002560. https://www.ncbi.nlm.nih.gov/pubmed/29470343.

ACOG. 2020. “Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin, Number 225.” Obstetrics & Gynecology 136 (4): e31-e47. https://doi.org/10.1097/aog.0000000000004082.

ACOG. 2021. “Informed Consent and Shared Decision Making in Obstetrics and Gynecology: ACOG Committee Opinion, Number 819.” Obstetrics & Gynecology 137 (2): e34-e41. https://doi.org/10.1097/aog.0000000000004247.

“Aid Access.” (website). Accessed June 8, 2022. https://aidaccess.org/en/i-need-an-abortion. https://aidaccess.org/en/page/561/who-are-we.

Aiken

A. R. A.

Romanova

E. P.

Morber

J. R.

Gomperts

. 2022. "Safety and Effectiveness of Self-managed Medication Abortion Provided Using Online Telemedicine in the United States: A Population-Based Study." Lancet Reg Health Am 10 (June 2022): 1–8. https://doi.org/10.1016/j.lana.2022.100200. https://www.sciencedirect.com/science/article/pii/S2667193X22000175?via%3Dihub.

American College of Obstetricians and Gynecologists et al., v. Food and Drug Administration et al., No. 20-1320, 2020 WL. 3960625 (D. Md. July 13, 2020). 2020. Accessed June 16, 2022. https://www.docketalarm.com/cases/Maryland_District_Court/8–20-cv01320/American_College_of_Obstetricians_%26_Gynecologists_et_al_v._United_States_Food_and_Drug_Administration_et_al/132/.

10.

Aronoff

D. M.

Hao

Chung

Coleman

Lewis

Peres

C. M.

Serezani

C. H.

, G. H., et al. 2008. “Misoprostol Impairs Female Reproductive Tract Innate Immunity Against Clostridium sordellii.” The Journal of Immunology 180 (12): 8222-8230. https://doi.org/10.4049/jimmunol.180.12.8222. https://www.ncbi.nlm.nih.gov/pubmed/18523288. https://www.jimmunol.org/content/jimmunol/180/12/8222.full.pdf.

11.

Aultman

Cirucci

C. A.

Harrison

D. J.

Beran

B. D.

Lockwood

M. D.

Seiler

. 2021. “Deaths and Severe Adverse Events After the use of Mifepristone as an Abortifacient from September 2000 to February 2019.” Issues Law Med 36 (1): 3-26. https://pubmed.ncbi.nlm.nih.gov/33939340/.

12.

Autry

B. M.

Wadhwa

. 2022. “Mifepristone.” In StatPearls, edited by Babak Abai, Abu-Ghosh, Amal, Acharya, Aninda B, Adhia, Sanjay G, Sedeh, Peyman Adibi, Aeby, Ted C, Aeddula, Narothama Reddy, et al. Treasure Island (FL): StatPearls Publishing. Copyright © 2022, StatPearls Publishing LLC, 1–4.

13.

Bartlett

L. A.

Berg

C. J.

Shulman

H. B.

Zane

S. B.

Green

C. A.

Whitehead

Atrash

H. K.

. 2004. “Risk Factors for Legal Induced Abortion-Related Mortality in the United States.” Obstetrics & Gynecology 103 (4): 729-737. https://doi.org/10.1097/01.AOG.0000116260.81570.60. https://www.ncbi.nlm.nih.gov/pubmed/15051566.

14.

Bennett

K. A.

Crane

J. M.

O'Shea

Lacelle

Hutchens

Copel

J. A.

. 2004. “First Trimester Ultrasound Screening is Effective in Reducing Postterm Labor Induction Rates: A Randomized Controlled Trial.” American Journal of Obstetrics and Gynecology 190 (4): 1077-1081. https://doi.org/10.1016/j.ajog.2003.09.065.

15.

Carlsson

Breding

Larsson

P. G.

. 2018. “Complications Related to Induced Abortion: A Combined Retrospective and Longitudinal Follow-up Study.” BMC Women's Health 18 (1): 158. https://doi.org/10.1186/s12905-018-0645-6. https://www.ncbi.nlm.nih.gov/pubmed/30253769.

16.

Center for Drug Evaluation and Research. 2000. “Approval Letter for Mifeprex NDA 20-687, September 28, 2000.” https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20687appltr.pdf.

17.

Center for Drug Evaluation and Research. 2016. “NDA 020687 MIFEPREX® (mifepristone) Tablets, 200 mg Risk Evaluation and Mitigation Strategy (REMS).” https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/020687Orig1s020RemsR.pdf.

18.

Chen

M. J.

Creinin

M. D.

. 2015. “Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.” Obstetrics & Gynecology 126 (1): 12-21. https://doi.org/10.1097/AOG.0000000000000897. https://escholarship.org/content/qt2pw521h5/qt2pw521h5.pdf?t=o42s03. https://www.ncbi.nlm.nih.gov/pubmed/26241251.

19.

Cirucci

C. A.

Aultman

K. A.

Harrison

D. J.

. 2021. “Mifepristone Adverse Events Identified by Planned Parenthood in 2009 and 2010 Compared to Those in the FDA Adverse Event Reporting System and Those Obtained Through the Freedom of Information Act.” Health Serv Res Manag Epidemiol 8(Jan-Dec 2021): 8–15. https://doi.org/10.1177/23333928211068919. https://journals.sagepub.com/doi/pdf/10.1177/23333928211068919.

20.

Cleland

Creinin

M. D.

Nucatola

Nshom

Trussell

. 2013. “Significant Adverse Events and Outcomes After Medical Abortion.” Obstet Gynecol 121 (1): 166-171. https://doi.org/http://10.1097/AOG.0b013e318275576310.1097/aog.0b013e3182755763. https://www.ncbi.nlm.nih.gov/pubmed/23262942.

21.

Danco Laboratories. 2016. “M I F E P R E X™ (Mifepristone) Tablets, 200 mg Prescriber's Agreement.” Accessed June 16, 2022. https://www.accessdata.fda.gov/drugsatfda_docs/rems/Mifeprex_2016-03-29_Prescriber_Agreement_Form.pdf.

22.

Department of Health and Human Services, Centers for Disease Control and Prevention, Food and Drug Administration, and National Institutes of Health. 2006. “Emerging Clostridial Disease Workshop May 11, 2006, Atlanta, Georgia, Certified Verbatim Transcript.” Emerging Clostridial Disease Workshop, Atlanta, GA, May 11, 2006. Accessed June 16, 2022. https://aaplog.wildapricot.org/resources/2006%20CDC%20FDA%20Clostridial%20Disease%20Transcript.pdf.

23.

“Doctor sentenced for spiking girlfriend's drink to induce abortion.” 2018. Accessed June 9, 2022. https://www.cbsnews.com/news/sikander-imran-doctor-sentenced-for-spiking-girlfriends-drink-to-induce-abortion/.

24.

Dovydaitis

. 2010. “Human Trafficking: The Role of the Health Care Provider.” Journal of Midwifery & Women's Health 55 (5): 462-467. https://doi.org/10.1016/j.jmwh.2009.12.017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125713/pdf/nihms295564.pdf.

25.

Endler

Lavelanet

Cleeve

Ganatra

Gomperts

Gemzell-Danielsson

. 2019. “Telemedicine for Medical Abortion: A Systematic Review.” BJOG: An International Journal of Obstetrics & Gynaecology 126 (9): 1094-1102. https://doi.org/10.1111/1471-0528.15684. https://www.ncbi.nlm.nih.gov/pubmed/30869829 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496179/pdf/BJO-126-1094.pdf.

26.

FDA. 2011. “NDA 20–687 MIFEPREX (mifepristone) Tablets, 200 mg; Risk Evaluation and Mitigation Strategy (REMS).” Accessed June 16, 2022. https://www.accessdata.fda.gov/drugsatfda_docs/rems/Mifeprex_2011-06-08_Full.pdf.

27.

FDA. 2018. “RCM # 2007-525, NDA 20-687, Mifepristone US Post-Marketing Adverse Events Summary through 12/31/2018.” Accessed June 16, 2022. https://www.fda.gov/media/112118/download.

28.

FDA. 2019. “Warning Letter Aidaccess.org MARCS-CMS 575658 - March 08, 2019. edited by FDA.” Accessed June 16, 2022. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aidaccessorg-575658-03082019.

29.

FDA. 2021a. “Questions and Answers on Mifeprex.” Accessed June 16, 2022. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/questions-and-answers-mifeprex; https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/questions-and-answers-mifeprex.

30.

FDA. 2021b. “Risk Evaluation and Mitigation Strategies, REMS.” Last Modified December 17, 2021. Accessed June 12. 2022. https://www.fda.gov/drugs/drug-safety-and-availability/risk-evaluation-and-mitigation-strategies-rems.

31.

“FDA Adverse Event Reporting System.” (website). Accessed June 8, 2022. https://fis.fda.gov/sense/app/95239e26-e0be-42d9-a960-9a5f7f1c25ee/sheet/7a47a261-d58b-4203-a8aa-6d3021737452/state/analysis.

32.

Galle

Semaan

Asefa

Benova

. 2021. “Telehealth use in Antenatal Care? Not Without Women's Voices.” The Lancet 398 (10309): 1405-1406. https://doi.org/10.1016/s0140-6736(21)01956-5. https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(21)01956-5.pdf.

33.

Gary

M. M.

Harrison

D. J.

. 2006. “Analysis of Severe Adverse Events Related to the use of Mifepristone as an Abortifacient.” Annals of Pharmacotherapy 40 (2): 191-197. https://doi.org/10.1345/aph.1G481. https://www.ncbi.nlm.nih.gov/pubmed/16380436.

34.

Gatter

Cleland

Nucatola

D. L.

. 2015. “Efficacy and Safety of Medical Abortion Using Mifepristone and Buccal Misoprostol Through 63 Days.” Contraception 91 (4): 269-273. https://doi.org/10.1016/j.contraception.2015.01.005. https://www.ncbi.nlm.nih.gov/pubmed/25592080. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373977/pdf/nihms662931.pdf.

35.

Goldberg

A. B.

Fulcher

I. R.

Fortin

Hofer

R. K.

Cottrill

Dethier

Gilbert

Janiak

Roncari

. 2022. “Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.” Obstetrics & Gynecology 139 (5): 771-780. https://doi.org/10.1097/aog.0000000000004756. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015019/pdf/ong-139-771.pdf.

36.

Goldstone

Michelson

Williamson

. 2012. “Early Medical Abortion Using low-Dose Mifepristone Followed by Buccal Misoprostol: A Large Australian Observational Study.” Medical Journal of Australia 197 (5): 282-286. https://doi.org/10.5694/mja12.10297. https://www.ncbi.nlm.nih.gov/pubmed/22938126. https://onlinelibrary.wiley.com/doi/10.5694/mja12.10297.

37.

Gomperts. 2019. “FDA vs. Aid Access: Aid Access Will Continue Providing Abortion Care.” Last Modified April 2019. Accessed June 12, 2022. https://aidaccess.org/en/page/200797/fda-vs-aid-access.

38.

Grossman

Grindlay

. 2017. “Safety of Medical Abortion Provided Through Telemedicine Compared With In Person.” Obstetrics & Gynecology 130 (4): 778-782. https://doi.org/10.1097/AOG.0000000000002212. https://www.ncbi.nlm.nih.gov/pubmed/28885427.

39.

Guttmacher Institute. 2022a. “Medication Abortion Now Accounts for More Than Half of All US Abortions.” Policy Analysis. Accessed June 16, 2022. https://www.guttmacher.org/article/2022/02/medication-abortion-now-accounts-more-half-all-us-abortions.

40.

Guttmacher Institute. 2022b. “Medication Abortion: State Laws and Policies as of June 1, 2022.” State Laws and Policies. Accessed June 17, 2022. https://www.guttmacher.org/state-policy/explore/medication-abortion.

41.

Gynuity. “TelAbortion: Safe. Effective. Private. Convenient.” (website). Accessed June 8, 2022. https://telabortion.org/.

42.

Hearn Law PLC, Richard A. Hearn. 2019. “RE: Warning Letter to Aidaccess.org and Dr. Rebecca Gomperts dated March 8, 2019.” Accessed June 1, 2022. https://aidaccess.org/en/media/inline/2019/5/16/19_05_16_gomperts_letter_and_exhibit_a.pdf.

43.

Ireland

L. D.

Gatter

Chen

A. Y.

. 2015. “Medical Compared With Surgical Abortion for Effective Pregnancy Termination in the First Trimester.” Obstetrics & Gynecology 126 (1): 22-28. https://doi.org/10.1097/AOG.0000000000000910. https://www.ncbi.nlm.nih.gov/pubmed/26241252.

44.

Kerns

Steinauer

. 2013. “Management of Postabortion Hemorrhage: Release Date November 2012 SFP Guideline #20131.” Contraception 87 (3): 331-342. https://doi.org/10.1016/j.contraception.2012.10.024. https://www.contraceptionjournal.org/article/S0010-7824(12)00954-7/pdf.

45.

Kortsmit

Mandel

M. G.

Reeves

J. A.

Clark

Pagano

H. P.

Nguyen

Petersen

E. E.

Whiteman

M. K.

. 2021. “Abortion Surveillance - United States, 2019.” MMWR. Surveillance Summaries 70 (9): 1-29. https://doi.org/10.15585/mmwr.ss7009a1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654281/pdf/ss7009a1.pdf.

46.

Lederer

Wetzel

C. A.

. 2014. “The Health Consequences of sex Trafficking and Their Implications for Identifying Victims in Healthcare Facilities.” Annals of Health Law 23 (1): 61-91. https://www.icmec.org/wp-content/uploads/2015/10/Health-Consequences-of-Sex-Trafficking-and-Implications-for-Identifying-Victims-Lederer.pdf.

47.

"Man accused of killing fetus with “abortion pancake.” 2014. CBS News . Last Modified July 14, 2014. Accessed June 16, 2022. https://www.cbsnews.com/news/man-accused-of-killing-fetus-with-abortion-pancake/.

48.

McBride

Jeannie

. 2017. “Doctor accused of spiking a local woman's drink with an abortion pill.” Accessed June 16, 2022. https://www.rochesterfirst.com/news/local-news/doctor-accused-of-spiking-a-local-womans-drink-with-an-abortion-pill/880161122/.

49.

Mentula

M. J.

Niinimaki

Suhonen

Hemminki

Gissler

Heikinheimo

. 2011. “Immediate Adverse Events After Second Trimester Medical Termination of Pregnancy: Results of a Nationwide Registry Study.” Human Reproduction 26 (4): 927-932. https://doi.org/10.1093/humrep/der016. https://www.ncbi.nlm.nih.gov/pubmed/21317416.

50.

Miech

R. P

. 2005. “Pathophysiology of Mifepristone-Induced Septic Shock due to Clostridium sordellii.” Annals of Pharmacotherapy 39 (9): 1483-1488. https://doi.org/10.1345/aph.1G189. https://www.ncbi.nlm.nih.gov/pubmed/16046483.

51.

“Mifeprex Prescribing Information Revised 3/2016.” 2016. Accessed June 17, 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020687s020lbl.pdf.

52.

National Academies of Science, Engineering, & Medicine. 2018. “The Safety and Quality of Abortion Care in the United States.” In The Safety and Quality of Abortion Care in the United States. Washington, DC: National Academies Press, 1–208. https://doi.org/10.17226/24950.

53.

Niinimaki

Pouta

Bloigu

Gissler

Hemminki

Suhonen

Heikinheimo

. 2009. “Immediate Complications After Medical Compared with Surgical Termination of Pregnancy.” Obstetrics & Gynecology 114 (4): 795-804. https://doi.org/10.1097/AOG.0b013e3181b5ccf9. https://www.ncbi.nlm.nih.gov/pubmed/19888037.

54.

Nivedita

Shanthini

. 2015. “Is It Safe to Provide Abortion Pills Over the Counter? A Study on Outcome Following Self-Medication with Abortion Pills.” Journal of Clinical and Diagnostic Research 9 (1): QC01-4. https://doi.org/10.7860/JCDR/2015/11626.5388. https://www.ncbi.nlm.nih.gov/pubmed/25738038.

55.

Pfizer. 2021. “Cytotec misoprostol tablets.” https://labeling.pfizer.com/ShowLabeling.aspx?format=PDF&id=559.

56.

“Plan C Guide to Abortion Pills, The: How to get abortion pill access by mail in Texas.” Plan C (website), accessed August 10, 2022. https://www.plancpills.org/states/texas.

57.

Raymond

Chong

Winikoff

Platais

Mary

Lotarevich

Castillo

P. W.

, B., et al. 2019. “TelAbortion: Evaluation of a Direct to Patient Telemedicine Abortion Service in the United States.” Contraception 100 (3): 173-177. https://doi.org/10.1016/j.contraception.2019.05.013. https://www.ncbi.nlm.nih.gov/pubmed/31170384. https://www.contraceptionjournal.org/article/S0010-7824(19)30176-3/fulltext.

58.

Raymond

E. G.

Shannon

Weaver

M. A.

Winikoff

. 2013. “First-trimester Medical Abortion with Mifepristone 200 mg and Misoprostol: A Systematic Review.” Contraception 87 (1): 26-37. https://doi.org/10.1016/j.contraception.2012.06.011. https://www.ncbi.nlm.nih.gov/pubmed/22898359. https://www.contraceptionjournal.org/article/S0010-7824(12)00643-9/pdf.

59.

“Safe at-home abortion is here, A.” Plan C (website). Accessed June 8, 2022. https://www.plancpills.org.

60.

Schmidt-Hansen

Cameron

Lord

Hasler

. 2020. “Initiation of Abortion Before There is Definitive Ultrasound Evidence of Intrauterine Pregnancy: A Systematic Review with Meta-Analyses.” Acta Obstetricia et Gynecologica SCAndinavica 99 (4): 451-458. https://doi.org/10.1111/aogs.13797. https://www.ncbi.nlm.nih.gov/pubmed/31883371 https://obgyn.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/aogs.13797?download=true.

61.

Siewert, Shereen. 2022. “Former Wausau-area man convicted of trying to kill unborn child with abortion pill.” Last Modified April 29, 2022. Accessed June 9, 2022. https://wausaupilotandreview.com/2022/04/29/former-wausau-area-man-convicted-of-trying-to-kill-unborn-child-with-abortion-pill/.

62.

Studnicki

Harrison

D. J.

Longbons

Skop

Reardon

D. C.

Fisher

J. W.

Tsulukidze

Craver

. 2021. “A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999-2015.” Health Services Research and Managerial Epidemiology 8 (Jan-Dec 2021): 1-11. https://doi.org/10.1177/23333928211053965. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581786/pdf/10.1177_23333928211053965.pdf.

63.

Supreme Court of the US. 2021. “Food and Drug Administration, et al. v. American College of Obstetricians and Gynecologists, et al. On Application for Stay. In 20A34 20a34.” https://www.supremecourt.gov/opinions/20pdf/20a34_3f14.pdf.

64.

Supreme Court of the United States. 2022. Dobbs, States Health Office of the Mississippi Department of Health, et al., v. Jackson Women's Health Organization et al. In 19-1392, edited by Supreme Court of the United States. 19-1392 Dobbs v. Jackson Women's Health Organization (06/24/2022) (supremecourt.gov).

65.

Upadhyay

U. D.

Desai

Zlidar

Weitz

T. A.

Grossman

Anderson

Taylor

. 2015. “Incidence of Emergency Department Visits and Complications After Abortion.” Obstetrics & Gynecology 125 (1): 175-183. https://doi.org/10.1097/AOG.0000000000000603. https://www.ncbi.nlm.nih.gov/pubmed/25560122. https://escholarship.org/content/qt523956jn/qt523956jn.pdf?t=opoj85.

66.

US Census Bureau. 2021 “Quick Facts.” Accessed August 5, 2022. https://www.census.gov/quickfacts/fact/table/US/RHI725221.

67.

US Government Accountability Office. 2018. “GAO-18-292 Information on Mifeprex Labeling Changes and Ongoing Monitoring Efforts.” Accessed June 16, 2022. https://www.gao.gov/assets/700/690914.pdf.

68.

Vauzelle

Beghin

Cournot

M. P.

Elefant

. 2013. “Birth Defects After Exposure to Misoprostol in the First Trimester of Pregnancy: Prospective Follow-up Study.” Reproductive Toxicology 36 (2013): 98–103. https://doi.org/10.1016/j.reprotox.2012.11.009. https://www.ncbi.nlm.nih.gov/pubmed/23207166. https://www.sciencedirect.com/science/article/abs/pii/S0890623812003462?via%3Dihub.

69.

Wang

Girgis

Cohen

Lee

. 2021. “Complications of Abortion and Need for Appropriate Ultrasound Assessment and Peri-Abortion Care.” Australian and New Zealand Journal of Obstetrics and Gynaecology 61 (4): 607-611. https://doi.org/10.1111/ajo.13354. https://obgyn.onlinelibrary.wiley.com/doi/10.1111/ajo.13354.

70.

“Wisconsin man spikes mistress’s drink with abortion drug, gets 22 years in prison.” 2018. Last Modified October 12, 2018. Accessed June 9, 2022. https://www.lifesitenews.com/news/wisconsin-husband-spikes-mistresss-drink-with-abortion-drug-gets-22-years/.

71.

Woodcock

Janet

. 2021. “FDA Letter to ACOG.” 2. https://www.sba-list.org/wp-content/uploads/2021/04/govdoc20210412-226601.pdf.

72.

Zipursky

Paul

V. K.

. 2011. “The Global Burden of Rh Disease.” Archives of Disease in Childhood - Fetal and Neonatal Edition 96 (2): F84-F85. https://doi.org/10.1136/adc.2009.181172. https://fn.bmj.com/content/96/2/F84.long.